1 |
Braun D, Judmann B, Cheng X, Wängler B, Schirrmacher R, Fricker G, Wängler C. Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α(v)β(3) Targeting. ACS Omega 2023;8:2793-807. [PMID: 36687076 DOI: 10.1021/acsomega.2c07484] [Reference Citation Analysis]
|
2 |
Damerow H, Wängler B, Schirrmacher R, Fricker G, Wängler C. Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of (68) Ga Labeling and Complex Stability Characteristics with Established Chelators. ChemMedChem 2023;18:e202200495. [PMID: 36259364 DOI: 10.1002/cmdc.202200495] [Reference Citation Analysis]
|
3 |
Uzal-Varela R, Patinec V, Tripier R, Valencia L, Maneiro M, Canle M, Platas-Iglesias C, Esteban-Gómez D, Iglesias E. On the dissociation pathways of copper complexes relevant as PET imaging agents. J Inorg Biochem 2022;236:111951. [PMID: 35963110 DOI: 10.1016/j.jinorgbio.2022.111951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
4 |
Judmann B, Braun D, Schirrmacher R, Wängler B, Fricker G, Wängler C. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors. ACS Omega. [DOI: 10.1021/acsomega.2c03407] [Reference Citation Analysis]
|
5 |
Tosato M, Verona M, Favaretto C, Pometti M, Zanoni G, Scopelliti F, Cammarata FP, Morselli L, Talip Z, van der Meulen NP, Di Marco V, Asti M. Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation. Molecules 2022;27:4158. [DOI: 10.3390/molecules27134158] [Reference Citation Analysis]
|
6 |
Hermann P, Kotek J, Kubíček V. Ten-Membered Rings or Lager With One or More Nitrogen Atoms. Comprehensive Heterocyclic Chemistry IV 2022. [DOI: 10.1016/b978-0-12-818655-8.00128-1] [Reference Citation Analysis]
|
7 |
Damerow H, Hübner R, Judmann B, Schirrmacher R, Wängler B, Fricker G, Wängler C. Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability. Cancers (Basel) 2021;13:6349. [PMID: 34944969 DOI: 10.3390/cancers13246349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
8 |
Tosato M, Dalla Tiezza M, May NV, Isse AA, Nardella S, Orian L, Verona M, Vaccarin C, Alker A, Mäcke H, Pastore P, Di Marco V. Copper Coordination Chemistry of Sulfur Pendant Cyclen Derivatives: An Attempt to Hinder the Reductive-Induced Demetalation in 64/67Cu Radiopharmaceuticals. Inorg Chem 2021;60:11530-47. [PMID: 34279088 DOI: 10.1021/acs.inorgchem.1c01550] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
9 |
Hübner R, Paretzki A, von Kiedrowski V, Maspero M, Cheng X, Davarci G, Braun D, Damerow H, Judmann B, Filippou V, Dallanoce C, Schirrmacher R, Wängler B, Wängler C. PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study. Pharmaceuticals (Basel) 2021;14:531. [PMID: 34199635 DOI: 10.3390/ph14060531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
10 |
Hübner R, von Kiedrowski V, Benkert V, Wängler B, Schirrmacher R, Krämer R, Wängler C. Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye. Pharmaceuticals (Basel) 2020;13:E250. [PMID: 32948032 DOI: 10.3390/ph13090250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
11 |
Judmann B, Braun D, Wängler B, Schirrmacher R, Fricker G, Wängler C. Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals (Basel) 2020;13:E173. [PMID: 32751666 DOI: 10.3390/ph13080173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
12 |
Pretze M, van der Meulen N, Wängler C, Schibli R, Wängler B. Targeted 64 Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. J Label Compd Radiopharm 2019;62:471-82. [DOI: 10.1002/jlcr.3736] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
13 |
Litau S, Seibold U, Wängler B, Schirrmacher R, Wängler C. iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with 68Ga and 64Cu: Unexpected Findings. ACS Omega 2018;3:14039-53. [PMID: 30411057 DOI: 10.1021/acsomega.8b01926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
14 |
Deng H, Wang H, Zhang H, Wang M, Giglio B, Ma X, Jiang G, Yuan H, Wu Z, Li Z. Imaging Neurotensin Receptor in Prostate Cancer With 64Cu-Labeled Neurotensin Analogs. Mol Imaging 2017;16:1536012117711369. [PMID: 28849698 DOI: 10.1177/1536012117711369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
15 |
Sarkar S, Bhatt N, Ha YS, Huynh PT, Soni N, Lee W, Lee YJ, Kim JY, Pandya DN, An GI, Lee KC, Chang Y, Yoo J. High in Vivo Stability of 64 Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates. J Med Chem 2018;61:385-95. [DOI: 10.1021/acs.jmedchem.7b01671] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
16 |
Hinsenkamp I, Schulz S, Roscher M, Suhr AM, Meyer B, Munteanu B, Fuchser J, Schoenberg SO, Ebert MP, Wängler B, Hopf C, Burgermeister E. Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer. Neoplasia 2016;18:500-11. [PMID: 27566106 DOI: 10.1016/j.neo.2016.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
|